Browsing by Subject "Therapeutics"
Now showing items 1-18 of 18
-
Advances in SARS-CoV-2: a systematic review
(2020-09-28)OBJECTIVE: In December 2019, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection broke out in Wuhan, China. However, we still lack a comprehensive understanding of this emerging virus. In this manuscript, ... -
Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review
(2020-10)Abstract The recently known coronavirus, SARS-CoV-2, has turn into the greatest global health challenge, affecting a large number of societies. The lack of specific treatment and gold-standard diagnostic system has made ... -
Controversial treatments: An updated understanding of the coronavirus disease 2019
(2020-03-26)An outbreak of severe acute respiratory syndrome‐related coronavirus 2 infection has posed significant threats to international health and the economy. In the absence of specific treatment for this virus, there is an urgent ... -
Directrices para el manejo farmacológico de pacientes críticos afectados por COVID-19 y otras comorbilidades (2 de abril de 2020)
(2020-04)El 1 de marzo del 2020, la República Dominicana, a través del Ministerio de Salud Pública dio a conocer el primer caso importado de COVID-19, un ciudadano de origen italiano, que ingreso en territorio dominicano. Al 22 de ... -
Directrices para el manejo farmacológico de pacientes críticos afectados por COVID-19 y otras comorbilidades, 2da. edición
(2020-06-26)En las presentes directrices se aborda el manejo farmacológico estandarizado de pacientes críticos afectados por la COVID-19, asociado a otras comorbilidades. -
Does TB Vaccination Reduce COVID-19 Infection?: No Evidence from a Regression Discontinuity Analysis
(2020-04-22)In the middle of the global COVID-19 pandemic, the BCG hypothesis, the prevalence and severity of the COVID-19 outbreak seems to be correlated with whether a country has a universal coverage of Bacillus-Calmette-Guerin ... -
Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
(2020-04-30)The rapidly progressing of coronavirus disease 2019 (COVID-19) pandemic has become a global concern. This meta-analysis aimed at evaluating the efficacy and safety of current option of therapies for severe acute respiratory ... -
Lineamientos técnicos para la atención clínica de personas con COVID-19, 3ra. edición
(2020)El presente documento se constituye en la tercera edición de los Lineamientos técnicos para la atención clínica de personas con enfermedad COVID-19, los cuales incluyen antecedentes, epidemiología, definiciones de casos, ... -
Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
(2020-09-18)The severe form of COVID-19 has significant sex disparities, with high fatalities commonly reported among males than females. The incidence of COVID-19 has also been higher in males compared with their female counterparts. ... -
National Institute for the Infectious Diseases “L. Spallanzani” IRCCS. Recommendations for COVID-19 Clinical Management
(2020-03-16)On January 9th, 2020, the “World Health Organization” (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a diseases (COVID-19) ranging ... -
Ongoing Living Update of Potential COVID-19 Therapeutics Options: Summary of Evidence. Rapid Review
(2020-12-18)Summary of rapid systematic reviews, from the 8th edition of the document and above. -
A Plausible Penny Costing Effective Treatment for Corona Virus - Ozone Therapy
(2020-03)Many viruses require reduced sulfhydryl groups for cell fusion and entry. Corona viruses, including SARS-CoV-2 (the cause of the condition now named coronavirus disease 2019 or COVID-19), are rich in cysteine, which residues ... -
Potential use of ozone in SARS-CoV-2 / COVID-19
(2020-03-14)Systemic ozone therapy can be “potentially” useful in SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown to be highly effective in research ... -
Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection
(2020-03-26)Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) has posed significant threats to the public health and life in China. Unlike the other 6 identified coronaviruses, the SARS-Cov-2 has a high infectious ... -
Protocolo para el diagnóstico y tratamiento del coronavirus (COVID-19) (marzo de 2020)
(2020-03)Debido a la importación de casos de COVID-19, la Organización Panamericana de la Salud/ Organización Mundial de la Salud (OPS/OMS) recomienda la vigilancia para detectar eventos respiratorios agudos, garantizar que los ... -
Serviço de produção de evidências para apoio à tomada de decisão: revisão sistemática rápida sobre tratamento para coronavírus humano. Atualização 01 (09 de março de 2020)
(2020-03-09)Trata-se da primeira atualização de uma Revisão Sistemática Rápida – estudo que categoriza, sumariza e apresenta uma síntese qualitativa ou quantitativa de evidências científicas sobre determinado tema – que buscou identificar ... -
Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS) RedeS
(2017)Stage A: To evaluate the safety and efficacy of the INTERCEPT Blood System for Red Blood Cells Pathogen Reduction Treatment (PRT) in comparison to conventional RBCs in adult patients who require RBC transfusion support. Stage ... -
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
(2020-03-28)A severe form of respiratory disease – COVID-19, caused by SARS-CoV-2 infection, has evolved into a pandemic resulting in significant morbidity and mortality. The unabated spread of the disease is due to lack of vaccine ...